SASH3 was also targeted by HAM/TSP and ATLL IgG in B cells, with additional unique targets such as SP110 nuclear body protein (SP110) and nuclear receptor coactivator 3 (NCOA3) identified in ATLL donors (Figure 2B). The gene discussed is SP110; the disease is adult T-cell leukemia/lymphoma.